Targeted Medical Pharma Appoints Two New Independent Members To The Board Of Directors

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced the addition of two independent members to the Company’s board of directors. The Company welcomes back health care specialist Kerry Weems to the board as an independent director and chairman of the Nominating and Governance Committee, as well as corporate finance expert Paul Pelosi, Jr. as an independent director.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC